Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-27 Sale |
2025-03-28 4:52 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
138,574 | $6.04 | $836,987 | 11,174,028 (Indirect Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 4:16 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $6.475 | $259,000 | 17,229,302 (Indirect Direct) |
View |
| 2025-02-05 Sale |
2025-02-07 4:14 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $7.9 | $316,000 | 17,326,434 (Indirect Direct) |
View |
| 2025-01-08 Sale |
2025-01-13 5:26 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $7.18 | $287,200 | 15,819,344 (Indirect Direct) |
View |
| 2024-12-04 Sale |
2024-12-06 5:46 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $7.14 | $285,600 | 15,899,344 (Indirect Direct) |
View |
| 2024-11-13 Sale |
2024-11-15 6:52 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $7.545 | $301,800 | 16,005,367 (Indirect Direct) |
View |
| 2024-11-12 Sale |
2024-11-14 7:19 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $7.6402 | $87,457 | 7,066,113 (Direct) |
View |
| 2024-11-12 Sale |
2024-11-14 7:19 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
30,000 | $7.6502 | $229,505 | 3,773,288 (Direct) |
View |
| 2024-10-29 Sale |
2024-10-31 6:01 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $6.7202 | $76,926 | 7,077,560 (Direct) |
View |
| 2024-10-24 Sale |
2024-10-28 5:25 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $6.3091 | $37,855 | 2,169,187 (Direct) |
View |
| 2024-10-15 Sale |
2024-10-17 5:27 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $6.6678 | $76,326 | 7,089,007 (Direct) |
View |
| 2024-10-08 Sale |
2024-10-10 6:40 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
30,000 | $6.3377 | $190,131 | 3,882,038 (Direct) |
View |
| 2024-10-02 Sale |
2024-10-04 6:30 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $6.12 | $244,800 | 16,085,367 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Tax Withholding |
2025-04-03 4:38 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
26,571 | $5.095 | 2,116,561 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 4:37 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
2,268 | $0 | 3,192,462 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 4:37 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
2,745 | $0 | 110,877 (Direct) |
View |
| 2025-03-17 Tax Withholding |
2025-03-19 4:27 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
7,057 | $6.84 | 2,143,132 (Direct) |
View |
| 2025-03-17 Option Award |
2025-03-19 4:27 pm |
N/A 2035-03-17 |
RECURSION PHARMACEUTICALS INC. | RXRX | Bumpus Namandje Director |
109,648 | $0 | 109,648 (Direct) |
View |
| 2025-03-17 Option Award |
2025-03-19 4:27 pm |
N/A 2035-03-17 |
RECURSION PHARMACEUTICALS INC. | RXRX | Sun Elaine D Director |
109,648 | $0 | 109,648 (Direct) |
View |
| 2025-03-05 Conversion |
2025-03-07 4:16 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $0 | 17,229,302 (Direct) |
View |
| 2025-02-18 Tax Withholding |
2025-02-20 4:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
17,132 | $10.64 | 11,352,602 (Direct) |
View |
| 2025-02-18 Tax Withholding |
2025-02-20 4:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
10,879 | $10.64 | 2,150,189 (Direct) |
View |
| 2025-02-05 Conversion |
2025-02-07 4:14 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $0 | 17,326,434 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 4:50 pm |
N/A 2035-02-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
118,977 | $0 | 2,161,068 (Direct) |
View |
| 2025-02-03 Tax Withholding |
2025-02-05 4:50 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
6,544 | $7.25 | 2,161,068 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 4:50 pm |
N/A 2035-02-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Khan Najat Chief R&D Commercial Officer |
638,388 | $0 | 2,126,551 (Direct) |
View |
| 2025-02-03 Tax Withholding |
2025-02-05 4:50 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Khan Najat Chief R&D Commercial Officer |
2,753 | $7.25 | 2,126,551 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 4:50 pm |
N/A 2035-02-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
1,592,659 | $0 | 10,742,836 (Direct) |
View |
| 2025-02-03 Tax Withholding |
2025-02-05 4:50 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,569 | $7.25 | 10,742,836 (Direct) |
View |
| 2025-01-08 Conversion |
2025-01-13 5:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $0 | 15,819,344 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 6:02 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
1,907 | $0 | 108,132 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 6:02 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,647 | $0 | 3,190,194 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 6:02 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
1,734 | $0 | 7,067,847 (Direct) |
View |
| 2024-12-19 Option Award |
2024-12-20 4:16 pm |
N/A 2034-12-18 |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
1,111,029 | $0 | 2,048,635 (Direct) |
View |
| 2024-12-17 Tax Withholding |
2024-12-18 6:49 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
7,057 | $6.95 | 473,867 (Direct) |
View |
| 2024-12-16 Tax Withholding |
2024-12-18 6:49 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
15,668 | $6.04 | 473,867 (Direct) |
View |
| 2024-12-04 Conversion |
2024-12-06 5:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $0 | 15,899,344 (Direct) |
View |
Ownership |
2024-12-02 7:02 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
0 | $0 | 960,331 (Direct) |
View |
| 2024-11-20 Option Award |
2024-11-22 6:25 pm |
N/A 2033-05-02 |
RECURSION PHARMACEUTICALS INC. | RXRX | Michor Franziska Director |
233,774 | $0 | 251,468 (Direct) |
View |
| 2024-11-15 Tax Withholding |
2024-11-19 6:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Mauro David J Chief Medical Officer |
4,187 | $6.175 | 706,392 (Direct) |
View |
| 2024-11-15 Tax Withholding |
2024-11-19 6:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
11,937 | $6.175 | 3,384,341 (Direct) |
View |
| 2024-11-15 Tax Withholding |
2024-11-19 6:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
14,286 | $6.175 | 2,154,901 (Direct) |
View |
| 2024-11-15 Tax Withholding |
2024-11-19 6:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
26,023 | $6.175 | 9,902,644 (Direct) |
View |
| 2024-11-13 Conversion |
2024-11-15 6:52 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $0 | 16,005,367 (Direct) |
View |
| 2024-11-12 Exercise |
2024-11-14 7:19 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $0 | 3,773,288 (Direct) |
View |
| 2024-11-12 Exercise |
2024-11-14 7:19 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $2.22 | 3,773,288 (Direct) |
View |
| 2024-10-24 Exercise |
2024-10-28 5:25 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $1.06 | 2,169,187 (Direct) |
View |
| 2024-10-24 Exercise |
2024-10-28 5:25 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $0 | 2,169,187 (Direct) |
View |
| 2024-10-08 Exercise |
2024-10-10 6:40 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $0 | 3,882,038 (Direct) |
View |
| 2024-10-08 Exercise |
2024-10-10 6:40 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $2.22 | 3,882,038 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-04 6:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
2,026 | $0 | 7,100,454 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-04 6:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
2,229 | $0 | 106,225 (Direct) |
View |
| 2024-10-02 Conversion |
2024-10-04 6:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $0 | 16,085,367 (Direct) |
View |